Atlas Trials

Dose Range Finding Study of Fedovapagon in Men With Nocturia

Clinical trial NCT01656239 · COMPLETED

Trial details

NCT number
NCT01656239
Sponsor
Vantia Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nocturia
Start date
2012-08-01
Primary completion
2013-08-01
Enrollment
358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.